We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

17 hedge funds and large institutions have $171K invested in Aethlon Medical in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0% → 0% (+0%)

6% less funds holding

Funds holding: 18 → 17 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

37% less capital invested

Capital invested by funds: $270K → $171K (-$99K)

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$11.6K
2
HF
HRT Financial
New York
+$5.13K
3
TSS
Two Sigma Securities
New York
+$1.28K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$7K
2
Mercer Global Advisors
Mercer Global Advisors
Colorado
-$5K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$4.65K
4
Two Sigma Investments
Two Sigma Investments
New York
-$2.57K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$2.57K

AEMD Hedge Fund Activity: Q3 2023 in Review

17 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2023, worth a combined $171K — down 37% from $270K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of AEMD and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.

The largest buyer was Geode Capital Management, adding an estimated $11.6K. The largest seller was Virtu Financial, exiting entirely with an estimated $7K sold.

  • 17 institutional investors held Aethlon Medical (AEMD) as of Q3 2023, down from 18 in Q2 2023.
  • Funds reported $171K of Aethlon Medical stock for Q3 2023, down 37% quarter-over-quarter.
  • 2 funds opened new Aethlon Medical positions in Q3 2023 and 3 closed out, a net change of -1 holder.
  • The largest Aethlon Medical buyer in Q3 2023 was Geode Capital Management, an estimated $11.6K added.
  • The largest Aethlon Medical seller in Q3 2023 was Virtu Financial, an estimated $7K sold.

Based on aggregated 13F filings for Q3 2023.